Buy & Sell Adaptive Biotechnologies Corp (ADPT) – Adaptive Biotechnologies Corp Price Today
Aura AI Summary
Key Stats
- $2.23BMarket Cap
- HealthSector
- -24.61%3M Drawdown
- $2.09BEnterprise Value
- -Dividend Yield
- 34 daysTypical Hold Time
Adaptive Biotechnologies Corp (ADPT) is currently valued at a market capitalization of $2.23B, with an enterprise value of $2.09B. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $8.84 and a high of $20.46, highlighting its annual price range. Over the past three months, Adaptive Biotechnologies Corp has recorded a drawdown of -24.61%, reflecting recent price volatility. On average, investors hold Adaptive Biotechnologies Corp for approximately 34 days, indicating typical investor behavior on the platform.
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Most Recent News
Verizon offers 2,500+ free FIFA World Cup 2026 tickets to US customers, plus exclusive FOX One streaming benefits.
Verizon announced it will distribute over 2,500 free tickets for all 64 FIFA World Cup 2026 matches held in US host cities exclusively to Verizon customers on June 1, 2026. Selected winners can also receive "Golden Tickets" for premium sideline exper...

US government invests $2B in quantum computing firms, boosting shares like Infleqtion and D-Wave Quantum.
The US government is investing $2 billion in nine quantum computing companies, including Infleqtion, D-Wave Quantum, and Rigetti Computing, as part of a strategy to advance quantum technology for economic and national security benefits. IBM and Globa...

Astec Industries execs to present at KeyBanc Industrials conference on May 27, 2026
Astec Industries announced that its CEO, CFO, and Senior VP of Investor Relations will participate in one-on-one meetings with investors at the KeyBanc Capital Markets Industrials and Basic Materials Conference on May 27, 2026. This event is an oppor...
